Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA
- 2 March 2017
- journal article
- research article
- Published by Wiley in International Journal of Urology
- Vol. 24 (4), 272-278
- https://doi.org/10.1111/iju.13314
Abstract
The results of the present study document patterns of care during a period of rapid and ongoing therapeutic advancement in advanced renal cell carcinoma. Sequencing of therapies warrants ongoing analysis in light of new agents entering the advanced renal cell carcinoma treatment landscape.Keywords
Funding Information
- Novartis
This publication has 29 references indexed in Scilit:
- Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy erasCancer Medicine, 2015
- Renal-Cell Cancer — Targeting an Immune Checkpoint or Multiple KinasesNew England Journal of Medicine, 2015
- Comparative Effectiveness of Second-Line Targeted Therapies for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World Observational StudiesPLOS ONE, 2014
- Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practicesCurrent Medical Research and Opinion, 2014
- Current and future systemic treatments for renal cell carcinomaSeminars in Cancer Biology, 2012
- Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Clinical EvidenceThe Oncologist, 2011
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature reviewCancer Treatment Reviews, 2008
- Sunitinib versus Interferon Alfa in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Metastatic renal cell carcinomaCurrent Treatment Options in Oncology, 2003